The 14-3-3 proteins in regulation of cellular metabolism

Seminars in Cell and Developmental Biology

Volumn 22, Issue 7, 2011, Pages 713-719

  Kleppe, Rune ^a   Martinez, Aurora ^a   Døskeland, Stein Ove ^a   Haavik, Jan ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

14 3 3 Proteins; Cell signaling; Membrane association; Metabolism; Tyrosine hydroxylase

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN 14 3 3;

AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL METABOLISM; DIABETES MELLITUS; ENZYME ACTIVATION; HUMAN; NEOPLASM; NONHUMAN; OBESITY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

EID: 80455164541     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.08.008     Document Type: Review

References (93)

1. Meek S.E., Lane W.S., Piwnica-Worms H. Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. J Biol Chem 2004, 279:32046-32054.
2. Pozuelo Rubio M., Geraghty K.M., Wong B.H., Wood N.T., Campbell D.G., Morrice N., et al. 14-3-3-Affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 2004, 379:395-408.
3. Jin J., Smith F.D., Stark C., Wells C.D., Fawcett J.P., Kulkarni S., et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004, 14:1436-1450.
4. Kjarland E., Keen T.J., Kleppe R. Does isoform diversity explain functional differences in the 14-3-3 protein family?. Curr Pharm Biotechnol 2006, 7:217-223.
5. Pozuelo-Rubio M. Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. FEBS J 2010, 277:3321-3342.
6. Chang I.F., Curran A., Woolsey R., Quilici D., Cushman J.C., Mittler R., et al. Proteomic profiling of tandem affinity purified 14-3-3 protein complexes in Arabidopsis thaliana. Proteomics 2009, 9:2967-2985.
7. Puri P., Myers K., Kline D., Vijayaraghavan S. Proteomic analysis of bovine sperm YWHA binding partners identify proteins involved in signaling and metabolism. Biol Reprod 2008, 79:1183-1191.
8. Benzinger A., Muster N., Koch H.B., Yates J.R., Hermeking H. Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 2005, 4:785-795.
9. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997, 91:961-971.
10. Johnson C., Crowther S., Stafford M.J., Campbell D.G., Toth R., MacKintosh C. Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J 2010, 427:69-78.
11. Uhart M., Iglesias A.A., Bustos D.M. Structurally constrained residues outside the binding motif are essential in the interaction of 14-3-3 and phosphorylated partner. J Mol Biol 2011, 406:552-557.
12. Fu H., Subramanian R.R., Masters S.C. 14-3-3 Proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000, 40:617-647.
13. Moreira J.M., Shen T., Ohlsson G., Gromov P., Gromova I., Celis J.E. A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences. Mol Cell Proteomics 2008, 7:1225-1240.
14. Kilani R.T., Medina A., Aitken A., Jalili R.B., Carr M., Ghahary A. Identification of different isoforms of 14-3-3 protein family in human dermal and epidermal layers. Mol Cell Biochem 2008, 314:161-169.
15. Schultz J., Ibrahim S.M., Vera J., Kunz M. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence. Mol Cancer 2009, 8:53.
16. He M., Zhang J., Shao L., Huang Q., Chen J., Chen H., et al. Upregulation of 14-3-3 isoforms in acute rat myocardial injuries induced by burn and lipopolysaccharide. Clin Exp Pharmacol Physiol 2006, 33:374-380.
17. Aksamit A., Korobczak A., Skala J., Lukaszewicz M., Szopa J. The 14-3-3 gene expression specificity in response to stress is promoter-dependent. Plant Cell Physiol 2005, 46:1635-1645.
18. Brunelli L., Cieslik K.A., Alcorn J.L., Vatta M., Baldini A. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta. Circ Res 2007, 100:e59-e71.
19. Patrick D.M., Zhang C.C., Tao Y., Yao H., Qi X., Schwartz R.J., et al. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev 2010, 24:1614-1619.
20. Tsukamoto Y., Nakada C., Noguchi T., Tanigawa M., Nguyen L.T., Uchida T., et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010, 70:2339-2349.
21. Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R., Ward H.L., et al. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 2003, 34:274-285.
22. Ikeda M., Hikita T., Taya S., Uraguchi-Asaki J., Toyo-oka K., Wynshaw-Boris A., et al. Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet 2008, 17:3212-3222.
23. Liu J., Zhou G., Ji W., Li J., Li T., Wang T., et al. No association of the YWHAE gene with schizophrenia, major depressive disorder or bipolar disorder in the Han Chinese population. Behav Genet 2011, 41:557-564.
24. Pers T.H., Hansen N.T., Lage K., Koefoed P., Dworzynski P., Miller M.L., et al. Meta-analysis of heterogeneous data sources for genome-scale identification of risk genes in complex phenotypes. Genet Epidemiol 2011, 35:318-332.
25. Grover D., Verma R., Goes F.S., Mahon P.L., Gershon E.S., McMahon F.J., et al. Family-based association of YWHAH in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:977-983.
26. Steinacker P., Schwarz P., Reim K., Brechlin P., Jahn O., Kratzin H., et al. Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein. Mol Cell Biol 2005, 25:1339-1346.
27. Komoike Y., Fujii K., Nishimura A., Hiraki Y., Hayashidani M., Shimojima K., et al. Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly. Genesis 2010, 48:233-243.
28. Liang X., Butterworth M.B., Peters K.W., Walker W.H., Frizzell R.A. An obligatory heterodimer of 14-3-3beta and 14-3-3epsilon is required for aldosterone regulation of the epithelial sodium channel. J Biol Chem 2008, 283:27418-27425.
29. Jones D.H., Ley S., Aitken A. Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett 1995, 368:55-58.
30. Chaudhri M., Scarabel M., Aitken A. Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem Biophys Res Commun 2003, 300:679-685.
31. Kligys K., Yao J., Yu D., Jones J.C. 14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytes. Biochem Biophys Res Commun 2009, 383:450-454.
32. Yamauchi T., Nakata H., Fujisawa H. A new activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+-, calmodulin-dependent protein kinase. Purification and characterization. J Biol Chem 1981, 256:5404-5409.
33. Huber S.C., MacKintosh C., Kaiser W.M. Metabolic enzymes as targets for 14-3-3 proteins. Plant Mol Biol 2002, 50:1053-1063.
34. Provan F., Haavik J., Lillo C. The regulatory phosphorylated serine in full-length nitrate redutase is necessary for optimal binding to a 14-3-3 protein. Plant Sci 2006, 170:394-398.
35. Roberts M.R. 14-3-3 Proteins find new partners in plant cell signalling. Trends Plant Sci 2003, 8:218-223.
36. Krebs E.G., Graves D.J., Fischer E.H. Factors affecting the activity of muscle phosphorylase b kinase. J Biol Chem 1959, 234:2867-2873.
37. Liang S., Yu Y., Yang P., Gu S., Xue Y., Chen X. Analysis of the protein complex associated with 14-3-3 epsilon by a deuterated-leucine labeling quantitative proteomics strategy. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:627-634.
38. Pozuelo Rubio M., Peggie M., Wong B.H., Morrice N., MacKintosh C. 14-3-3s Regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase. EMBO J 2003, 22:3514-3523.
39. Ichimura T., Isobe T., Okuyama T., Yamauchi T., Fujisawa H. Brain 14-3-3 protein is an activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+, calmodulin-dependent protein kinase II. FEBS Lett 1987, 219:79-82.
40. Winge I., McKinney J.A., Ying M., D'Santos C.S., Kleppe R., Knappskog P.M., et al. Activation and stabilization of human tryptophan hydroxylase 2 by phosphorylation and 14-3-3 binding. Biochem J 2008, 410:195-204.
41. Kleppe R., Toska K., Haavik J. Interaction of phosphorylated tyrosine hydroxylase with 14-3-3 proteins: evidence for a phosphoserine 40-dependent association. J Neurochem 2001, 77:1097-1107.
42. Itagaki C., Isobe T., Taoka M., Natsume T., Nomura N., Horigome T., et al. Stimulus-coupled interaction of tyrosine hydroxylase with 14-3-3 proteins. Biochemistry 1999, 38:15673-15680.
43. Banik U., Wang G.A., Wagner P.D., Kaufman S. Interaction of phosphorylated tryptophan hydroxylase with 14-3-3 proteins. J Biol Chem 1997, 272:26219-26225.
44. Toska K., Kleppe R., Armstrong C.G., Morrice N.A., Cohen P., Haavik J. Regulation of tyrosine hydroxylase by stress-activated protein kinases. J Neurochem 2002, 83:775-783.
45. Haavik J., Martinez A., Flatmark T. pH-dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation of Ser-40. FEBS Lett 1990, 262:363-365.
46. Bobrovskaya L., Dunkley P.R., Dickson P.W. Phosphorylation of Ser19 increases both Ser40 phosphorylation and enzyme activity of tyrosine hydroxylase in intact cells. J Neurochem 2004, 90:857-864.
47. Bevilaqua L.R., Graham M.E., Dunkley P.R., von Nagy-Felsobuki E.I., Dickson P.W. Phosphorylation of Ser(19) alters the conformation of tyrosine hydroxylase to increase the rate of phosphorylation of Ser(40). J Biol Chem 2001, 276:40411-40416.
48. McKinney J., Knappskog P.M., Haavik J. Different properties of the central and peripheral forms of human tryptophan hydroxylase. J Neurochem 2005, 92:311-320.
49. Ganguly S., Weller J.L., Ho A., Chemineau P., Malpaux B., Klein D.C. Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205. Proc Natl Acad Sci U S A 2005, 102:1222-1227.
50. Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol Rev 2009, 89:1025-1078.
51. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 2004, 23:833-843.
52. Benton R., Palacios I.M., St Johnston D. Drosophila 14-3-3/PAR-5 is an essential mediator of PAR-1 function in axis formation. Dev Cell 2002, 3:659-671.
53. Al-Hakim A.K., Goransson O., Deak M., Toth R., Campbell D.G., Morrice N.A., et al. 14-3-3 Cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J Cell Sci 2005, 118:5661-5673.
54. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
55. Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G., Jeffries S., et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74.
56. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
57. Jung C.H., Jun C.B., Ro S.H., Kim Y.M., Otto N.M., Cao J., et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009, 20:1992-2003.
58. Li Y., Inoki K., Vacratsis P., Guan K.L. The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J Biol Chem 2003, 278:13663-13671.
59. Li Y., Inoki K., Yeung R., Guan K.L. Regulation of TSC2 by 14-3-3 binding. J Biol Chem 2002, 277:44593-44596.
60. DeYoung M.P., Horak P., Sofer A., Sgroi D., Ellisen L.W. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 2008, 22:239-251.
61. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008, 30:214-226.
62. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011, 13:132-141.
63. Lee J.W., Park S., Takahashi Y., Wang H.G. The association of AMPK with ULK1 regulates autophagy. PLoS One 2010, 5:e15394.
64. Pozuelo-Rubio M. Regulation of autophagic activity by 14-3-3zeta proteins associated with class III phosphatidylinositol-3-kinase. Cell Death Differ 2011, 18:479-492.
65. Qi X.J., Wildey G.M., Howe P.H. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem 2006, 281:813-823.
66. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628.
67. Nomura M., Shimizu S., Sugiyama T., Narita M., Ito T., Matsuda H., et al. 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 2003, 278:2058-2065.
68. Maiuri M.C., Criollo A., Tasdemir E., Vicencio J.M., Tajeddine N., Hickman J.A., et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007, 3:374-376.
69. Sancak Y., Thoreen C.C., Peterson T.R., Lindquist R.A., Kang S.A., Spooner E., et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 2007, 25:903-915.
70. Vander Haar E., Lee S.I., Bandhakavi S., Griffin T.J., Kim D.H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007, 9:316-323.
71. Fonseca B.D., Smith E.M., Lee V.H., MacKintosh C., Proud C.G. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 2007, 282:24514-24524.
72. Roach W.G., Chavez J.A., Miinea C.P., Lienhard G.E. Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. Biochem J 2007, 403:353-358.
73. Zeigerer A., McBrayer M.K., McGraw T.E. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 2004, 15:4406-4415.
74. Chen S., Murphy J., Toth R., Campbell D.G., Morrice N.A., Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 2008, 409:449-459.
75. Chen S., Wasserman D.H., MacKintosh C., Sakamoto K. Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 2011, 13:68-79.
76. Agarwal-Mawal A., Qureshi H.Y., Cafferty P.W., Yuan Z., Han D., Lin R., et al. 14-3-3 Connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 2003, 278:12722-12728.
77. Chen C.H., Shaikenov T., Peterson T.R., Aimbetov R., Bissenbaev A.K., Lee S.W., et al. ER stress inhibits mTORC2 and Akt signaling through GSK-3beta-mediated phosphorylation of rictor. Sci Signal 2011, 4:ra10.
78. Kumar A., Harris T.E., Keller S.R., Choi K.M., Magnuson M.A., Lawrence J.C. Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity. Mol Cell Biol 2008, 28:61-70.
79. Gardino A.K., Smerdon S.J., Yaffe M.B. Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. Semin Cancer Biol 2006, 16:173-182.
80. Hekman M., Albert S., Galmiche A., Rennefahrt U.E., Fueller J., Fischer A., et al. Reversible membrane interaction of BAD requires two C-terminal lipid binding domains in conjunction with 14-3-3 protein binding. J Biol Chem 2006, 281:17321-17336.
81. Obsilova V., Vecer J., Herman P., Pabianova A., Sulc M., Teisinger J., et al. 14-3-3 Protein interacts with nuclear localization sequence of forkhead transcription factor FoxO4. Biochemistry 2005, 44:11608-11617.
82. Shikano S., Coblitz B., Wu M., Li M. 14-3-3 Proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends Cell Biol 2006, 16:370-375.
83. Smith A.J., Daut J., Schwappach B. Membrane proteins as 14-3-3 clients in functional regulation and intracellular transport. Physiology (Bethesda) 2011, 26:181-191.
84. Halskau O., Muga A., Martinez A. Linking new paradigms in protein chemistry to reversible membrane-protein interactions. Curr Protein Pept Sci 2009, 10:339-359.
85. Bustad H.J., Underhaug J., Halskau O., Martinez A. The binding of 14-3-3γ to membranes studied by intrinsic fluorescence spectroscopy. FEBS Lett 2011, 585:1163-1168.
86. Kaufman S. Tyrosine hydroxylase. Adv Enzymol Relat Areas Mol Biol 1995, 70:103-220.
87. Cartier E.A., Parra L.A., Baust T.B., Quiroz M., Salazar G., Faundez V., et al. A biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles. J Biol Chem 2010, 285:1957-1966.
88. Sakiyama H., Wynn R.M., Lee W.R., Fukasawa M., Mizuguchi H., Gardner K.H., et al. Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an alpha-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. J Biol Chem 2008, 283:24899-24908.
89. Yaffe M.B. How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 2002, 513:53-57.
90. Hoops S., Sahle S., Gauges R., Lee C., Pahle J., Simus N., et al. COPASI - a COmplex PAthway Simulator. Bioinformatics 2006, 22:3067-3074.
91. Fu H, et al. Seminars in cell and developmental biology 2011;22 [this issue].
92. Camoni L., Di Lucente C., Visconti S., Aducci P. The phytotoxin fusicoccin promotes platelet aggregation via 14-3-3-glycoprotein Ib-IX-V interaction. Biochem J 2011, 436:429-436.
93. Gardino A, Yaffe M. 14-3-3 Proteins As Signaling Integration Points for Cell Cycle Control and Apoptosis. Sem Cell Dev Bio 2011.(submitted).